title: [Some clarifications regarding botulinum toxin type A units. Reply].
authors.affiliation: Hospital del Sureste de la Comunidad de Madrid, Arganda del Rey, Espana.
authors.forename: H
authors.initials: H
authors.lastname: Alonso-Navarro
authors.forename: F J
authors.initials: FJ
authors.lastname: Jimenez-Jimenez
authors.forename: J F
authors.initials: JF
authors.lastname: Plaza-Nieto
authors.forename: B
authors.initials: B
authors.lastname: Pilo-De la Fuente
authors.forename: F
authors.initials: F
authors.lastname: Navacerrada
authors.forename: M
authors.initials: M
authors.lastname: Arroyo-Solera
authors.forename: M
authors.initials: M
authors.lastname: Calleja
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002012:Bruxism / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A